This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Sanofi, Sanofi-Aventis. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2016
Title: Sylvie Wentzler: Innovator in Pharmaceutical Chemistry
Introduction
Sylvie Wentzler is a notable inventor based in Paris, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of MET inhibitors. With a total of 4 patents to her name, her work has garnered attention in the scientific community.
Latest Patents
Wentzler's latest patents include innovative compounds such as 6-triazolopyridazine sulfanyl benzothiazole derivatives, which serve as MET inhibitors. The disclosures relate to compounds of formula (I), wherein A, W, X, and Ra are defined in the disclosure. These compounds are not only important for their chemical properties but also for their potential use as medicaments.
Career Highlights
Throughout her career, Sylvie Wentzler has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. Her experience in these organizations has allowed her to develop and refine her expertise in drug development and innovation.
Collaborations
Wentzler has collaborated with several professionals in her field, including Conception Nemecek and Eva Albert. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Sylvie Wentzler's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of new medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile